BY

      DR. ANIMESH ARYA

 CONSULTANT PULMONOLOGIST
MAX HOSPITAL AND BALAJI ACTION
     MEDICAL INSTITUTE
         NEW DELHI
58 YRS FEMALE OBESE H/O
DOE FOR 2 YRS PROGRESSIVE
ADMITTED FOR INVESTIGATION
AND BEING TREATED FOR HYPOXIC
RESPIRATORY FAILURE
   Lung window shows bilateral reticularity in the right and the left mid
    zones anterioly ( right>left ) with A haze suggestive of interestitial
    thickening with interestitial pnuemonitis.
   Some alveolar opacities are also seen amidst the above suggestive of
    the alveolar exudates. The apical basal segments of both lower lobes
    also show reticularity with haze suggestive of interestitial thickening
    and interestitial pnuemonitis
   The right lower zone shows an area of rounded cystic air spaces
    suggestive of areas of bronchiectasis. Some area of bronchiectasis are
    also seen in the above apical basal patches of pnuemonitis. A tiny
    emphysematous bulla is seen in the right upper zone peripharally.basal
    early honeycombing is seen.
 Fob and lavage and TBLB
 Treatment with steroids
 Pulse therapy VS. regular dose
 OLB and the treat /not treat
 Supportive
   THE LUMEN OF ALVEOLI SHOW DESQUAMMATED EPITHILIAL
    CELLS
   THE WALL IS THICKENED EXPANDED AT CERTAIN FOCII BY
    COLLAGENOUS TISSUE WHILE AT PLACES THERE ARE LYMPHOID
    AGGREGATES.
   CERTAIN ALVEOLAR SPACES SHOW PLASMA CELL, LYMPHOCYTES
    AND FEW HISTOCYTE COLLECTIONS.
   THE TERMINAL BRONCHIOLES ARE THICKENED, WITH
    COLLAGENOUS WALL AROUND IT.
   SECTION B FROM THE MIDDLE LOBE SHOW CERTAIN NORMAL
    LOOKING ALVEOLI WHILE AT PLACES THE INTERESTITIUM IS
    EXPANDED LYMPHOMONONUCLEAR CELLS
 FEATURES OF DIP IN THE MIDDLE LOBE AND
 FEATURES OF DIP AND UIP IN THE LOWER
  LOBE
 A CRP diagnosis of UIP made with acute
  exacerbation
 Treated with steroids 30 mg /day and
  azathioprine with oxygen and diuretics and
  LTOT
 Uneventful course initially with worsening to
  resting hypoxia without oxygen and gr. IV
  dyspnoea
   INCRESED ABDOMINAL FULLNESS, ACIDITY, FREQUENCY OF STOOLS AND
    SHORTNESS OF BREATH ON WALKING UPTO ABOUT A KM. GR I – II DYSPNOEA
    in may2006
   NO H/O WHEEZING. CHEST PAIN                             H/OCOUGH,
    EXPECTORATION,SLIGHTLY YELLOWISH TO HGIC
   NO PEDAL OEDEMA, NO CHEST PAIN , PND,ORTHOPNOEA
   NO SIGNIFICANT PAST HISTORY
   PATIENT IS EX SMOKER – 30 PACK-YEARS TILL ABOUT 6 MONTHS BACK
   ALCOHOLIC –LEFT SINCE 3 MONTHS
   AS PER RECORD AVAILABLE WITH US GPE/
    NAD, S/E NAD

 PREVIOUS HISTORY- TMT IN MAY 2005- NAD
 REFERRED TO CHEST SPECIALST
   HB-16.2
   TLC-6800, P71,L22,M1,E6, ESR =10MM
   URINE –NAD
   BLOOD SUGAR 131
   CXR
 FVC=3.52/3.58 (98%)
 FEV1=2.83/2.88 (98%)
 FET==6.81 Seconds
 PEFR=8.08/7.02 lps (115%)
 FEF 25-75 =2.89/3.14 (92%)
   Non contrast HRCT scan was done
   Multiple patchy foci of consolidation showing a predominantly
    peripheral distribution seen at the lung bases bilaterally. The largest
    lesion is seen in the right lower lobe abutting the pleura with an
    adjacent area of ground glass density. Other lesions are significantly
    smaller and are seen in both the lower lobes as well as lingula and the
    middle lobe
   B/L peripherally distributed patchy consolidation/infiltrates are also
    seen
   No lymphadenopathy
   Radiological D/D – nonspecific shadows, ?infective, ?BOOP, ?EP,?OP
 WAIT AND WATCH AS PT. IS MILDLY
  SYMPTOMATIC?
 INVESTIGATE?
 WHICH INVESTIGATIONS?
   CONSULTED ANOTHER CHEST PHYSICIAN AND
    TREATED WITH AB. FOR A WEEK AND REVIEW AGAIN
    AND INVESIGATE FOR AFB SMEAR AND CULTURE FOR
    THREE DAYS, AND SPUTUM CULTURE
   SP CULTURE NEGATIVE, SP AFB NEG FOR 3 DAYS
   HIS COUGH WORSENED AND THE SPUTUM WAS MORE
    BLOOD TINGED
   HE THEN REPORTED TO US FOR FOB AND
    BIOPSY WITH INTENT TO RULE OUT
    MALIGNANCY (SUGGESTED BY
    SOMEBODY)
   MX TEST, ACE LEVEL ,HIV, TEMP RECORD AND
    BRONCHOSCOPY
   FOB PERFORMED
   MILD PURULENT SECRETIONS COMING OUT OF
    APICAL AND POSTERIOR BASAL SEGMENTS OF
    RLL, APICAL SEGMENT WAS NAROWED
   SENT FOR CYTOLOGY, AFB CULTURES AND TBLB
    TAKEN FROM THE RLL APICAL SEGMENT
   CYTOLOGY, INCONCLUSIVE AFB SMEAR -NEG
   BIOPSY- A PIECE OF BRONCHIAL MUCOSA, IT
    HAS PSEUDOSTRATIFIED LINING
    DISCONTINUOUS AT PLACES THERE IS
    SUBMUCOUSAL LYMPHONUCLEAR INFILTRATE,
    FEW FOAMY CELLS.AND A FEW ILL DEFINED
    GRANULOMAS
   IMP: EPITHELOID GRANULOMATOUS
    INFLAMMATION BRONCHIAL TISSUE - ?CAUSE
 TUBERCULOSIS
 ALVEOLAR SARCOID
 OP
 PUMONARY VASULITIS
 ???? IIP
   PATIENT WAS TOLD OF THE REPORT AND HE
    DISCUSSED THIS WITH THREE DIFFERENT
    PULMONOLOGISTS AND THE OPINION WAS VARIED
    ABOUT
   1. ATT,
   2. ATT AND STEROIDS
   3. STEROIDS
   4 .WAIT AND WATCH FOR CULTURE
    HOWEVER PATIENT WAS STARTED ON
    ANTITUBERCULAR TREATMENT WITH 4 DRUGS
    WITH THE CONSENT OF THE PT.
   His symptoms worsened and the patient became
    dyspnoeic, with worsening hemoptysis and loss of
    weight
   His CXR did not show much change , RATHER
    WORSENED
   He was suggested to take steroids and discontinue ATT
    but he again went to at least three more pulmonologists
    and all agreed to same approach
   In the mean time to get sputa for AFB for 3 more days,
     c-ANCA, p-ANCA, ACE levels, complement levels, repeat
    urine exam and ENT exam
   All investigations came out to be normal. Meanwhile pt’s
    dyspnoea worsened.
   He was suggested repeat CT scan thorax and PFT
   FVC: 2.04 vs 3.52
   FEV1: 1.61 vs
    2.83
   CT Report (18-8-05): There is marked volume loss of
    both lower lobes which show areas of collapse
    consolidatoion in both the lung bases. Evidence of
    thickened interstitium with ground glass density are also
    seen. Similar changes are evident in few areas of
    middle lobe and lingula. A few scattered infiltrates are
    seen in the upper lobes but these portions of lung are
    mostly spared. There is no lymph nodes and or pleural
    effusion
   There is marked progression of lesions as compared to
    the previous scan of 30-6-05.
   No definitive radiological opinion was volunteered.
   Patient was advised to undergo OLB at this
    stage for a conclusive diagnosis
   Pt refused procedure and continued on steroids
   Went to AIIMS and subjected to FOB and TBLB
    again ON 26/08/05
   Biopsy result-shows respiratory epithelium,
    subepithelium showing mild thickening of the
    interalveolar septae and sparse chronic
    inflammatory infiltrate. The possibility of
    inflammatory lung disease can not be ruled out
    in the small biopsy.
 REPEAT FOB WITH BAL
 OPEN LUNG BIOPSY AND MICROBIOLOGICAL
  SAMPLING
 CHANGE MX WITH ADDITION OF
  IMMUNOSUPPRESSIVES
   D/D ??
   Continued on steroids and we reemphasised the
    need for a firm diagnosis by larger biopsy by way
    of OLB
   Patient undergoes open lung biosy on 14/09/05 at
    another institute after consulting five
    pulmonologists in Delhi and Bombay
   Reported as widening of the interstitial tissue
    which is infiltrated by the inflammatory cells. Some
    of the alveolar lumina contain macrophages and
    chronic inflammatory cells consisting of
    lymphocytes - Intersitial Pneumonitis of Lung
   Review of OLB in AIIMS - Compatible with
    organising pneumonia. No granuloma seen
   Review at another institution - UIP
 INTERSTITIAL PNEUMONIA
 VARIETY?
     UIP
     NSIP-SUBTYPE=
       CELLULAR
       FIBROTIC
       MIXED
       -OP-FIBROTIC   NSIP
 After OLB patient was also given
  azathioprine besides steroids
 Meanwhile AFB culture on lung biopsy and
  bronchial aspirate came out to be negative
   WAS THE CLINICAL DIAGNOSIS CORRECT?
   DID WE MISS AT ANY INVESTIGATION?
   WAS APPROACH CORRECT?
    FOB AND BIOPSY WERE INADEQUATE AND
    CONFUSING
   OLB DID IT GIVE US THE FINAL ANSWER?
   VARIANCE OF VARIOUS PATHOLOGISTS
    IMPRESSION
 NSIP
 OP-NSIP
 ?? USUAL INTERSTITIAL PNEUMONITIS
 ?? UIP WITH COP
 ?? COP
 ???? OTHER
   DIFFICULT TO ARRIVE AT A DIAGNOSIS
   BETTER CLINICAL , RADIOLOGIC AND SURICAL
    CORELATION IS MANDATORY
   OPEN LUNG BIOPSY IS THE NEED OF THE HOUR ,
    CAN BE EASILY PERFORMED BUT PERHAPS THE
    APPROPRIATE INTERPRETATION OF THE FINDINGS
    IS STILL ELUSIVE AND MAY NOT BE THE GOLD
    STANDARD
 48 MALE, NON SMOKER
 DOE -2MONTHS
 REVIEWD BY PHYSICIANS
 NO DIAGNOSIS
 CXR – BASAL LINEAR SHADOWS

  LOSS OF LUNG VOLUME
  EXAM –BIBASILAR FINE CRACKLES
ADVISED CT SCAN CHEST AND PFT
 PATCHY GROUND GLASS
 LOSS OF LUNG VOLUMES
 NO THICKENING OF INTERSTITIUM
 NO HONEY COMB

INTERSTITIAL PNEUMONITIS-NSIP
PFT – RESTRICTIVE DISORDER
 FOB AND LAVAGE – INCONCLUSIVE
 TREATMENT AS CELLULAR NSIP
     PULSE 1 GM OF METHYLPREDNISOLONE X 3
      DAYS AND THEN
     START ON 10 MG WYSOLONE AND
      AZATHIOPRINE 50 MG/DAY
   DOE –HIGH INDEX OF SUSPICION
   MUST R/OOTHER DISEASES
   A HIGH QUALITY CT-WITH A CR CONF
   AGOOD PFT WITH DLCO MANDATORY
   TIME PLANE
   HIGH PROBABLITY OF IIP
   ALGORITMIC APPROACH
   IF DIA CERTAIN NO NEED FOR OLB , FOB COULD BE DONE TO
    R/O INFECTIONS
   BAL ROLE IN INDIA
   IF OLB ATTEMPED SELECT THE SITE NO. SIZE AND GOOD
    PATHOLOGIST
 TREATMENT
 AIM AT WHAT
 POTENTIAL CURE
 CELLULAR/GG-TREAT /PULSES
 FIBROTIC –NO GOOD ONLY SUPPORTIVE
 NEWER DRUGS-NAC /OTHERS
Interstitial Lung Disease
Interstitial Lung Disease

Interstitial Lung Disease

  • 1.
    BY DR. ANIMESH ARYA CONSULTANT PULMONOLOGIST MAX HOSPITAL AND BALAJI ACTION MEDICAL INSTITUTE NEW DELHI
  • 2.
    58 YRS FEMALEOBESE H/O DOE FOR 2 YRS PROGRESSIVE ADMITTED FOR INVESTIGATION AND BEING TREATED FOR HYPOXIC RESPIRATORY FAILURE
  • 14.
    Lung window shows bilateral reticularity in the right and the left mid zones anterioly ( right>left ) with A haze suggestive of interestitial thickening with interestitial pnuemonitis.  Some alveolar opacities are also seen amidst the above suggestive of the alveolar exudates. The apical basal segments of both lower lobes also show reticularity with haze suggestive of interestitial thickening and interestitial pnuemonitis  The right lower zone shows an area of rounded cystic air spaces suggestive of areas of bronchiectasis. Some area of bronchiectasis are also seen in the above apical basal patches of pnuemonitis. A tiny emphysematous bulla is seen in the right upper zone peripharally.basal early honeycombing is seen.
  • 15.
     Fob andlavage and TBLB  Treatment with steroids  Pulse therapy VS. regular dose  OLB and the treat /not treat  Supportive
  • 16.
    THE LUMEN OF ALVEOLI SHOW DESQUAMMATED EPITHILIAL CELLS  THE WALL IS THICKENED EXPANDED AT CERTAIN FOCII BY COLLAGENOUS TISSUE WHILE AT PLACES THERE ARE LYMPHOID AGGREGATES.  CERTAIN ALVEOLAR SPACES SHOW PLASMA CELL, LYMPHOCYTES AND FEW HISTOCYTE COLLECTIONS.  THE TERMINAL BRONCHIOLES ARE THICKENED, WITH COLLAGENOUS WALL AROUND IT.  SECTION B FROM THE MIDDLE LOBE SHOW CERTAIN NORMAL LOOKING ALVEOLI WHILE AT PLACES THE INTERESTITIUM IS EXPANDED LYMPHOMONONUCLEAR CELLS
  • 17.
     FEATURES OFDIP IN THE MIDDLE LOBE AND  FEATURES OF DIP AND UIP IN THE LOWER LOBE
  • 18.
     A CRPdiagnosis of UIP made with acute exacerbation  Treated with steroids 30 mg /day and azathioprine with oxygen and diuretics and LTOT  Uneventful course initially with worsening to resting hypoxia without oxygen and gr. IV dyspnoea
  • 19.
    INCRESED ABDOMINAL FULLNESS, ACIDITY, FREQUENCY OF STOOLS AND SHORTNESS OF BREATH ON WALKING UPTO ABOUT A KM. GR I – II DYSPNOEA in may2006  NO H/O WHEEZING. CHEST PAIN H/OCOUGH, EXPECTORATION,SLIGHTLY YELLOWISH TO HGIC  NO PEDAL OEDEMA, NO CHEST PAIN , PND,ORTHOPNOEA  NO SIGNIFICANT PAST HISTORY  PATIENT IS EX SMOKER – 30 PACK-YEARS TILL ABOUT 6 MONTHS BACK  ALCOHOLIC –LEFT SINCE 3 MONTHS
  • 20.
    AS PER RECORD AVAILABLE WITH US GPE/ NAD, S/E NAD  PREVIOUS HISTORY- TMT IN MAY 2005- NAD  REFERRED TO CHEST SPECIALST
  • 21.
    HB-16.2  TLC-6800, P71,L22,M1,E6, ESR =10MM  URINE –NAD  BLOOD SUGAR 131  CXR
  • 24.
     FVC=3.52/3.58 (98%) FEV1=2.83/2.88 (98%)  FET==6.81 Seconds  PEFR=8.08/7.02 lps (115%)  FEF 25-75 =2.89/3.14 (92%)
  • 30.
    Non contrast HRCT scan was done  Multiple patchy foci of consolidation showing a predominantly peripheral distribution seen at the lung bases bilaterally. The largest lesion is seen in the right lower lobe abutting the pleura with an adjacent area of ground glass density. Other lesions are significantly smaller and are seen in both the lower lobes as well as lingula and the middle lobe  B/L peripherally distributed patchy consolidation/infiltrates are also seen  No lymphadenopathy  Radiological D/D – nonspecific shadows, ?infective, ?BOOP, ?EP,?OP
  • 31.
     WAIT ANDWATCH AS PT. IS MILDLY SYMPTOMATIC?  INVESTIGATE?  WHICH INVESTIGATIONS?
  • 32.
    CONSULTED ANOTHER CHEST PHYSICIAN AND TREATED WITH AB. FOR A WEEK AND REVIEW AGAIN AND INVESIGATE FOR AFB SMEAR AND CULTURE FOR THREE DAYS, AND SPUTUM CULTURE  SP CULTURE NEGATIVE, SP AFB NEG FOR 3 DAYS  HIS COUGH WORSENED AND THE SPUTUM WAS MORE BLOOD TINGED  HE THEN REPORTED TO US FOR FOB AND BIOPSY WITH INTENT TO RULE OUT MALIGNANCY (SUGGESTED BY SOMEBODY)
  • 33.
    MX TEST, ACE LEVEL ,HIV, TEMP RECORD AND BRONCHOSCOPY  FOB PERFORMED  MILD PURULENT SECRETIONS COMING OUT OF APICAL AND POSTERIOR BASAL SEGMENTS OF RLL, APICAL SEGMENT WAS NAROWED  SENT FOR CYTOLOGY, AFB CULTURES AND TBLB TAKEN FROM THE RLL APICAL SEGMENT
  • 34.
    CYTOLOGY, INCONCLUSIVE AFB SMEAR -NEG  BIOPSY- A PIECE OF BRONCHIAL MUCOSA, IT HAS PSEUDOSTRATIFIED LINING DISCONTINUOUS AT PLACES THERE IS SUBMUCOUSAL LYMPHONUCLEAR INFILTRATE, FEW FOAMY CELLS.AND A FEW ILL DEFINED GRANULOMAS  IMP: EPITHELOID GRANULOMATOUS INFLAMMATION BRONCHIAL TISSUE - ?CAUSE
  • 35.
     TUBERCULOSIS  ALVEOLARSARCOID  OP  PUMONARY VASULITIS  ???? IIP
  • 36.
    PATIENT WAS TOLD OF THE REPORT AND HE DISCUSSED THIS WITH THREE DIFFERENT PULMONOLOGISTS AND THE OPINION WAS VARIED ABOUT  1. ATT,  2. ATT AND STEROIDS  3. STEROIDS  4 .WAIT AND WATCH FOR CULTURE HOWEVER PATIENT WAS STARTED ON ANTITUBERCULAR TREATMENT WITH 4 DRUGS WITH THE CONSENT OF THE PT.
  • 39.
    His symptoms worsened and the patient became dyspnoeic, with worsening hemoptysis and loss of weight  His CXR did not show much change , RATHER WORSENED  He was suggested to take steroids and discontinue ATT but he again went to at least three more pulmonologists and all agreed to same approach  In the mean time to get sputa for AFB for 3 more days, c-ANCA, p-ANCA, ACE levels, complement levels, repeat urine exam and ENT exam  All investigations came out to be normal. Meanwhile pt’s dyspnoea worsened.  He was suggested repeat CT scan thorax and PFT
  • 41.
    FVC: 2.04 vs 3.52  FEV1: 1.61 vs 2.83
  • 51.
    CT Report (18-8-05): There is marked volume loss of both lower lobes which show areas of collapse consolidatoion in both the lung bases. Evidence of thickened interstitium with ground glass density are also seen. Similar changes are evident in few areas of middle lobe and lingula. A few scattered infiltrates are seen in the upper lobes but these portions of lung are mostly spared. There is no lymph nodes and or pleural effusion  There is marked progression of lesions as compared to the previous scan of 30-6-05.  No definitive radiological opinion was volunteered.
  • 55.
    Patient was advised to undergo OLB at this stage for a conclusive diagnosis  Pt refused procedure and continued on steroids  Went to AIIMS and subjected to FOB and TBLB again ON 26/08/05  Biopsy result-shows respiratory epithelium, subepithelium showing mild thickening of the interalveolar septae and sparse chronic inflammatory infiltrate. The possibility of inflammatory lung disease can not be ruled out in the small biopsy.
  • 56.
     REPEAT FOBWITH BAL  OPEN LUNG BIOPSY AND MICROBIOLOGICAL SAMPLING  CHANGE MX WITH ADDITION OF IMMUNOSUPPRESSIVES
  • 57.
    D/D ??  Continued on steroids and we reemphasised the need for a firm diagnosis by larger biopsy by way of OLB
  • 58.
    Patient undergoes open lung biosy on 14/09/05 at another institute after consulting five pulmonologists in Delhi and Bombay  Reported as widening of the interstitial tissue which is infiltrated by the inflammatory cells. Some of the alveolar lumina contain macrophages and chronic inflammatory cells consisting of lymphocytes - Intersitial Pneumonitis of Lung  Review of OLB in AIIMS - Compatible with organising pneumonia. No granuloma seen  Review at another institution - UIP
  • 59.
     INTERSTITIAL PNEUMONIA VARIETY?  UIP  NSIP-SUBTYPE=  CELLULAR  FIBROTIC  MIXED  -OP-FIBROTIC NSIP
  • 60.
     After OLBpatient was also given azathioprine besides steroids  Meanwhile AFB culture on lung biopsy and bronchial aspirate came out to be negative
  • 61.
    WAS THE CLINICAL DIAGNOSIS CORRECT?  DID WE MISS AT ANY INVESTIGATION?  WAS APPROACH CORRECT?  FOB AND BIOPSY WERE INADEQUATE AND CONFUSING  OLB DID IT GIVE US THE FINAL ANSWER?  VARIANCE OF VARIOUS PATHOLOGISTS IMPRESSION
  • 64.
     NSIP  OP-NSIP ?? USUAL INTERSTITIAL PNEUMONITIS  ?? UIP WITH COP  ?? COP  ???? OTHER
  • 66.
    DIFFICULT TO ARRIVE AT A DIAGNOSIS  BETTER CLINICAL , RADIOLOGIC AND SURICAL CORELATION IS MANDATORY  OPEN LUNG BIOPSY IS THE NEED OF THE HOUR , CAN BE EASILY PERFORMED BUT PERHAPS THE APPROPRIATE INTERPRETATION OF THE FINDINGS IS STILL ELUSIVE AND MAY NOT BE THE GOLD STANDARD
  • 67.
     48 MALE,NON SMOKER  DOE -2MONTHS  REVIEWD BY PHYSICIANS  NO DIAGNOSIS  CXR – BASAL LINEAR SHADOWS LOSS OF LUNG VOLUME EXAM –BIBASILAR FINE CRACKLES ADVISED CT SCAN CHEST AND PFT
  • 77.
     PATCHY GROUNDGLASS  LOSS OF LUNG VOLUMES  NO THICKENING OF INTERSTITIUM  NO HONEY COMB INTERSTITIAL PNEUMONITIS-NSIP PFT – RESTRICTIVE DISORDER
  • 78.
     FOB ANDLAVAGE – INCONCLUSIVE  TREATMENT AS CELLULAR NSIP  PULSE 1 GM OF METHYLPREDNISOLONE X 3 DAYS AND THEN  START ON 10 MG WYSOLONE AND AZATHIOPRINE 50 MG/DAY
  • 108.
    DOE –HIGH INDEX OF SUSPICION  MUST R/OOTHER DISEASES  A HIGH QUALITY CT-WITH A CR CONF  AGOOD PFT WITH DLCO MANDATORY  TIME PLANE  HIGH PROBABLITY OF IIP  ALGORITMIC APPROACH  IF DIA CERTAIN NO NEED FOR OLB , FOB COULD BE DONE TO R/O INFECTIONS  BAL ROLE IN INDIA  IF OLB ATTEMPED SELECT THE SITE NO. SIZE AND GOOD PATHOLOGIST
  • 109.
     TREATMENT  AIMAT WHAT  POTENTIAL CURE  CELLULAR/GG-TREAT /PULSES  FIBROTIC –NO GOOD ONLY SUPPORTIVE  NEWER DRUGS-NAC /OTHERS